Switzerland
# |
Name |
Inventory |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 9.20 B
|
Dec. 31, 2023 | USD 345.60 | 2.71% |
|
Switzerland |
|
2 |
USD 8.68 B
|
Dec. 31, 2023 | USD 179.67 | -1.84% |
|
Switzerland |
|
3 |
USD 8.61 B
|
March 31, 2024 | USD 197.09 | 1.20% |
|
Switzerland |
|
4 |
USD 5.72 B
|
Dec. 31, 2024 | USD 109.34 | 3.55% |
|
Switzerland |
|
5 |
USD 2.32 B
|
Dec. 31, 2023 | USD 92.96 | 1.64% |
|
Switzerland |
|
6 |
USD 1.90 B
|
Dec. 31, 2024 | USD 679.88 | 1.57% |
|
Switzerland |
|
7 |
USD 1.35 B
|
Dec. 31, 2023 | USD 78.19 | 0.12% |
|
Switzerland |
|
8 |
USD 1.26 B
|
Dec. 31, 2023 | USD 45.50 | 0.26% |
|
Switzerland |
|
9 |
USD 482.86 M
|
March 31, 2024 | USD 342.71 | 1.66% |
|
Switzerland |
|
10 |
USD 89.07 M
|
Dec. 31, 2023 | USD 25.29 | -1.32% |
|
Switzerland |
|
11 |
USD 83.45 M
|
March 31, 2024 | USD 398.72 | 2.69% |
|
Switzerland |
|
12 |
USD 81.12 M
|
Dec. 31, 2023 | USD 75.75 | -0.61% |
|
Switzerland |
|
13 |
USD 61.48 M
|
Dec. 31, 2023 | USD 22.25 | 0.61% |
|
Switzerland |
|
14 |
USD 29.91 M
|
Dec. 31, 2023 | USD 87.62 | 1.69% |
|
Switzerland |
|
15 |
USD 20.97 M
|
Dec. 31, 2023 | USD 165.26 | 1.08% |
|
Switzerland |
|
16 |
USD 0.00
|
Dec. 31, 2023 | USD 22.91 | 2.51% |
|
Switzerland |
|
17 |
USD 0.00
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
|
18 |
USD 0.00
|
Dec. 31, 2023 | USD 561.20 | 0.41% |
|
Switzerland |
The Eyewear company in Switzerland with the highest Inventory is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD 9.20 B.
The Eyewear company in Switzerland with the lowest Inventory is Vaudoise Assurances Holding SA (Swiss Stock Exchange: VAHN.SW) at USD 0.00.
The top 10 Eyewear companies in Switzerland by Inventory are Roche Holding AG, The Swatch Group AG, Compagnie Financière Richemont SA, Novartis AG, Alcon Inc., Lonza Group AG, DKSH Holding AG, Avolta AG, Sonova Holding AG and CALIDA Holding AG.
The bottom 10 Eyewear companies in Switzerland by Inventory are Vaudoise Assurances Holding SA, Molecular Partners AG, Oculis Holding AG, IVF Hartmann Holding AG, Orell Füssli AG, DocMorris AG, Medartis Holding AG, Ypsomed Holding AG, CALIDA Holding AG and Sonova Holding AG.